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We performed a cross-sectional study to analyze the retinal vasculature in children, adolescent, and young adults with type 1
diabetes using optical coherence tomography angiography (OCTA). Patients underwent funduscopic examination for diabetic
retinopathy (DR) screening during an annual visit for the screening of diabetes-related complications which included the
evaluation of glycated hemoglobin (HbA1c), microalbuminuria, lipid profile, arterial pressure, and neurological assessment. In
addition, OCTA of the retinal vasculature was performed. Quantitative analysis of the OCTA images evaluated the vessel
density at the superficial (SCP) and deep (DCP) capillary plexus of the retina. Structural vascular alterations were evaluated
qualitatively. Results were compared to those obtained in a group of healthy age-, sex-, and pubertal stage-matched controls.
The effect of age, disease duration, age at the disease onset, mean HbA1c since the onset, and lipid profile on vascular density
was tested. Fifty-three patients (median age 15.5, IQR 12.4-19.4 years; 57% females) with type 1 diabetes and 48 controls were
enrolled. The median (IQR) HbA1c was 7.6% (60 mmol/mol) (6.9-8.1%, 52-65 mmol/mol), and the median (IQR) duration of
disease was 6.0 (3.3-10.3) years. Mean vessel density measured with OCTA was lower in patients compared to controls with the
temporal sector showing the highest difference both in the SCP (0.55 vs. 0.57, p < 0 001) and the DCP (0.63 vs. 0.65, p < 0 001).
None of the predictors was associated with the superficial and deep vascular densities. Only 2 patients had clinically detectable
DR. Microvascular structural changes were found on OCTA in both of these patients and in one without funduscopic
alterations. In conclusion, patients with type 1 diabetes without clinically detectable DR had decreased capillary density
compared to controls on OCTA images. These findings may provide useful information for the screening and the management
of patients with type 1 diabetes. Further studies are needed to confirm our results and their clinical relevance.
1. Introduction
Type 1 diabetes is the most common metabolic disorder of
childhood and adolescence. Its onset in pediatric age together
with suboptimal metabolic control puts patients at a greater
risk of developing diabetes-related complications [1].
Diabetic retinopathy (DR) is one of themost feared complica-
tions of diabetes, leading to visual impairment and blindness
if untreated. DR is uncommon before puberty, especially in
children aged less than 15 years [2]. The reported prevalence
of DR in children and young adults ranges from 10% to 58%
depending on the studied population [3–7].
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The development and progression of DR depend on
several modifiable (glucose control, smoking, arterial hyper-
tension, dyslipidemia, and obesity) and nonmodifiable (age,
duration of disease, pubertal status, and genetic predisposi-
tion) factors [8]. The pathogenesis of DR is far from being
completely elucidated. Changes in retinal blood vessel mor-
phology and retinal blood flow have been reported in DR,
but little is known about blood flow alterations during
preclinical stages. Functional alterations such as increased
vascular permeability and leukostasis have been shown to
precede pericyte loss and vascular remodeling [9].
The only available imaging technique to evaluate retinal
vasculature before 2000s was fluorescein angiography. This
is an invasive examination, requiring an intravenous dye
injection, with the risk of local and systemic adverse events.
Over the last 4 years, a novel noninvasive technique named
optical coherence tomography angiography (OCTA) has
been introduced in the clinical practice [10]. OCTA provides
a noninvasive, rapid, high-resolution assessment of retinal
vascular layers with no need for dye injection. Since its intro-
duction in the clinical practice, OCTA has been applied to
several eye diseases offering pathogenetic and prognostic
insights. A great advantage of OCTA vs. fluorescein angiog-
raphy is its ability to study separately the different retinal vas-
cular layers and split the superficial (SCP) from deep (DCP)
retinal capillary plexus [10].
Recent studies using OCTA have shown that adults
affected by diabetes have low capillary density and that adult
patients with type 1 diabetes without clinically evident DR
have SCP and DCP anomalies [11–15]. To the best of our
knowledge, only one study used OCTA to evaluate retinal
vessel density in children affected by type 1 diabetes and
found no alterations of SCP, DCP, and the fovea avascular
zone [16].
The aim of the present cross-sectional study was to use
OCTA to evaluate the retinal perfusion of children, adoles-
cents, and young adults with type 1 diabetes and to compare
OCTA findings of these patients with a group of age- and
sex-matched healthy controls.
2. Materials and Methods
2.1. Subjects. This cross-sectional study was performed
between May 1st, 2017, and July 31st, 2017, on consecutive
patients affected by type 1 diabetes followed up at the Diabe-
tes Clinic of the Vittore Buzzi Children’s Hospital (ASST
Fatebenefratelli-Sacco, Milan, Italy). The patients were being
regularly followed up at our clinic since the diagnosis of type
1 diabetes, and the data for the present study were collected
during an annual visit for the screening of diabetes-related
complications.
The inclusion criteria were diagnosis of type 1 diabetes,
intensive insulin therapy, age between 6 and 25 years, and
diabetes duration for at least 6 months. The exclusion criteria
were type 2 diabetes mellitus, maturity onset diabetes of the
young and syndromic diabetes (e.g., diabetes associated with
Down syndrome), myopia exceeding 6.00 diopters, history of
nondiabetic retinal disease, previous ocular surgery or laser
treatments, ocular media opacities, and poor cooperation.
Healthy sex-, pubertal stage-, and age-matched controls were
recruited at the Eye Clinic in Luigi Sacco Hospital Milan. The
exclusion criteria for controls were myopia exceeding 6.00
diopters, history of any retinal disease, previous ocular
surgery or laser treatment, ocular media opacities, and poor
cooperation.
Each patient affected by type 1 diabetes underwent a
medical, neurological, and comprehensive ophthalmological
examination including best-corrected visual acuity (BCVA)
assessment, fundus examination, and OCTA as described in
detail below [17]. The healthy control underwent BVCA
assessment, fundus examination, and OCTA.
All procedures were free of charge and paid by the
National Health System.
The study was conducted according to the Declaration of
Helsinki and was approved by the local Ethical Committee.
Written informed consent was obtained from the subjects
aged 18 years or older or from the parents of those younger
than 18 years.
2.2. Clinical Assessment. The following data were collected
for each patient at the time of OCTA: gender, ethnicity,
age, height, weight, body mass index (BMI), age at diagnosis
of type 1 diabetes, disease duration, type of insulin therapy
(multiple daily injections or MDI; continuous subcutaneous
insulin infusion or CSII), and insulin requirement
(unit/kg/day).
The standard deviation scores (SDS) of weight, height,
and BMI were calculated using the World Health Organiza-
tion (WHO) [18] and the Italian reference data [19]. The
pubertal stage was assessed according to Tanner and White-
house [20]. Tanner stages 1 and 2 were combined as prepu-
bertal/early pubertal, stages 3 and 4 as pubertal, and stage 5
as postpubertal development.
Systolic blood pressure and diastolic blood pressure were
measured following international guidelines [21].
Blood samples were obtained after a 10-hour
overnight fast. Creatinine, total cholesterol (TC), high-
density lipoprotein cholesterol (HDL), low-density lipo-
protein cholesterol (LDL), and triglycerides (TG) were
measured using standard laboratory methods. We used
standard cut-off values for levels of total cholesterol
(hypercholesterolemia ≥ 200mg per deciliter), HDL choles-
terol (hypoHDL < 40mg per deciliter and <50 mg/dl for
females > 16 years), LDL cholesterol (hyperLDL ≥ 130mg
per deciliter), and triglycerides (hyperTG ≥ 150mg per
deciliter) [22].
HbA1c was measured using a fully automated high-
performance liquid chromatography system (Variant II,
Bio-Rad Laboratories, Munich, Germany).
A first morning urine sample was obtained in all patients
to evaluate microalbuminuria.
All samples were analyzed by the laboratory of ASST-
Fatebenefratelli Sacco.
The following data were obtained from the medical
charts: glycated hemoglobin (HbA1c) at diagnosis and every
3 months, number of hospital admissions for diabetic ketoa-
cidosis (DKA), number of severe hypoglycemic episodes, and
presence of diabetes-related complications.
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2.3. Ophthalmological Assessment. All study subjects under-
went a complete ophthalmological examination including
BCVA assessment, slit lamp examination, and funduscopic
examination performed by a senior ophthalmologist (MP).
Pupils were dilated with 1% tropicamide before funduscopic
examination and OCTA image collection.
OCTA images were obtained using the split-spectrum
amplitude-decorrelation angiography algorithm (SSADA)
on the AngioVue OCT-A system version 2017.1.0.15 (Opto-
vue RTVue XR Avanti, Optovue Inc., Freemont, California,
USA). This device uses an 840 nm wavelength laser to cap-
ture 70,000 A-scans per second; 304 A-scans made up a B-
scan, while 304 vertical and horizontal lines were sampled
in the scanning area to obtain a 3D data cube. 3 × 3 and 6
× 6mm volume scans centered onto the fovea were
performed in both eyes for each patient.
Automated segmentation of SCP and DCP was per-
formed using the inbuilt software algorithm which sets the
inner margin of SCP at 3 μm below the internal limiting
membrane of the retina and the outer boundary at 15 μm
beneath the inner plexiform layer (IPL), with the DCP top
boundary set at 15 μm beneath the IPL and the bottom
margin at 71 μm under the IPL.
Vascular density was calculated with the AngioVue Ana-
lytics software, which reports the relative density of flow as
percentage of the total area. In detail, the vessel density was
defined as the percentage of area occupied by vessel lumens
after binary reconstruction of images. In the present study,
vessel density was calculated for different sectors (superior,
nasal, inferior, and temporal) based on the Early Treatment
Diabetic Retinopathy Study (ETDRS) chart with the fovea
position automatically determined from OCTA. The parafo-
vea was defined as the area within an annulus located
between 1 and 2.5 mm from the central fovea.
The SCP and DCP vascular data were analyzed sepa-
rately. For statistical analysis, we collected the SCP and
DCP foveal and parafoveal data from 3 × 3mm volumetric
scans, and the superior, nasal, inferior, and temporal data
from 6 × 6mm images. Data from both eyes of all subjects
were considered for analysis (see below).
A qualitative evaluation of the OCTA images was also
performed by two double-masked ophthalmologists (MP
and CP). For each image, the following DR angiographic fea-
tures were evaluated on both SPC and DPC OCTA images:
presence of microaneurysms, rarefaction of perifoveal capil-
laries, capillary tortuosity, and disruption of the perifoveolar
capillary arcades.
2.4. Statistical Analysis. Most continuous variables were not
Gaussian-distributed, and all are reported as median and
interquartile range (IQR). Discrete variables are reported as
the number and proportion of subjects with the characteristic
of interest. Between-group comparisons were performed
using a fractional generalized linear model (GLM) with a
logit link and cluster confidence intervals [23, 24]. The out-
come of the fractional GLM was the vascular density (frac-
tion, with theoretical limits from 0 to 1) of the regions of
interest (SCP and DCP foveal, parafoveal, temporal, superior,
nasal, and inferior areas), and the predictor was type 1
diabetes (discrete: 0 = no; 1 = yes). For each subject, we ana-
lyzed both the eyes of each subject in the same model using
cluster confidence intervals to take into account the fact that
every subject contributed two eyes to the analysis [23].
Because of the 14 multiple comparisons involving SCP and
DCP, a significant p value was set at p < 0 003 (0.05/14).
The effect of age, disease duration, age at disease onset, mean
HbA1c, LDL, HDL, TG, and TC on vascular density was
tested adding each predictor to the fractional GLM.
3. Results
3.1. Patients. Fifty-five consecutive patients affected by type 1
diabetes were eligible for the study, but two refused to
participate. Fifty-three patients with type 1 diabetes were
hence included in the analysis. The median (IQR) age was
15.5 (12.4-19.4) years. Thirty (57%) patients were female,
and 27 (51%) were being treated with CSII. The median
(IQR) HbA1c was 7.6% (60 mmol/mol) (6.9-8.1%, 52-65
mmol/mol), and the median (IQR) duration of disease was
6.0 (3.3-10.3) years. No patient had arterial hypertension,
and all patients had a normal neurological evaluation. Two
patients had microalbuminuria, i.e., >30 mg/g creatinine/-
day. The median (IQR) HbA1c from the onset to OCTA
was 7.5% (58 mmol/mol) (IQR 7.0-8.0%/53-64 mmol/mol).
HyperTC and hyperLDL were detected in 3 patients. Two
patients had hyperTG and 6 patients hypoHDL. Detailed
data about the 53 patients with type 1 diabetes at the time
of OCTA are reported in Table 1.
Forty-eight healthy subjects with a median (IQR) age of
13.7 (11.0-18.9) years served as controls. Forty-five (94%)
of them were Caucasians, and 26 (54%) were girls.
3.2. Eyes. A total of 106 (53 × 2) eyes from patients with type
1 diabetes and 96 (48 × 2) eyes from healthy controls were
analyzed. Tables S1 and S2 report the vascular densities of
the SCP and DCP plexus for the right and left eyes of
patients with type 1 diabetes and healthy controls. These
tables are reported only for descriptive purposes because
the comparison between the vascular densities of the SCP
and DCP plexus of patients with type 1 diabetes and
healthy controls was performed on both eyes using a
fractional GLM treating the eyes as clusterized in a given
subject (see Statistical Analysis for details).
Vascular density was decreased in patients affected by
type 1 diabetes compared to healthy subjects in all the regions
of interest in both the superficial and deep plexus with the
exception of the fovea. After Bonferroni correction, in the
superficial plexus, the mean difference in vascular density
between diabetics and controls was significant only in the
temporal and the superior regions (0.57 vs. 0.55%, p < 0 001
and 0.57 vs. 0.55%, p = 0 002, respectively). In the deep
plexus, the difference was significant only in the temporal
region (0.65 vs. 0.63%, p < 0 001). Table 2 gives the mean
(95% confidence intervals (95% CI)) vascular densities for
the SCP and DCP in patients with type 1 diabetes and healthy
controls estimated by the fractional GLM model described
under Statistical Analysis. As shown in Table S3, none of
the additional predictors was associated in a clinically
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relevant way with the superficial and deep vascular densities
evaluated by OCTA. (The presence of statistical significance
for few predictors was expected by chance alone because of
the number of tested models [96] and is clearly irrelevant
because the contribution was always negligible on clinical
grounds).
OCTA images were reviewed by 2 masked operators with
good agreement, and vascular abnormalities were detected in
3 cases (Figure 1).
4. Discussion
DR has long been considered extremely rare in pediatric
age. However, a recent large US study has shown an
increase of 20% (95% CI 6 to 35%) of the hazard of DR
for every 1-point increase of HbA1c in children with type
1 diabetes [25]. Moreover, DR seems to progress rapidly in
children with type 1 diabetes, so its early detection can be
beneficial [25].
The worldwide increase in the incidence of type 1 diabe-
tes mandates the consideration of strategies for the early
detection of DR. OCTA may be one of such strategies as
studies of diabetic adults have shown that OCTA can detect
alterations of retinal blood flow in the presence of normal
fundus examinations [14, 15].
In the present study, we found that OCTA was able to
detect significantly lower retinal vessel density in temporal
SCP (0.55 vs. 0.57) and DCP (0.63 vs. 0.65) in both eyes of
patients with type 1 diabetes mostly with no clinically detect-
able DR compared to healthy children. Reduced vessel
density was also detected in the other regions of interest of
both SCP and DCP of the same eyes except for the foveal
region. This partially confirms recent studies reporting
vascular changes in the DCP of patients affected by type 1
diabetes [12, 13].
Our results are intriguing since they demonstrate that
OCTA can identify early microvascular changes that occur
in the retina before the DR becomes clinically visible and that
are consequently not detectable with the standard screening
procedures. However, the clinical significance of the differ-
ences we found in capillary density between patients
affected by type 1 diabetes and controls is unclear because
Table 1: Patient characteristics.
Patient with type 1 diabetes Healthy controls
N (%) Median (IQR) N (%) Median (IQR)
Gender 53 48
Female 30 (57%) 26 (54%)
Male 23 (43%) 22 (46%)
Age (years) 53 15.5 (12.4; 19.4) 48 13.7 (11.8-18.9)
Caucasian 53 48
No 7 (13%) 3 (6%)
Yes 46 (87%) 45 (94%)
Weight (kg) 52 59 (45; 65)
Height (m) 52 1.62 (1.54; 1.71)
BMI (kg/m2) 52 21.4 (19.3; 23.8)
Weight (SDS Cacciari) 38 0.02 (-0.54; 0.86)
Height (SDS Cacciari) 38 0.23 (-0.41; 0.95)
BMI (SDS Cacciari) 38 -0.08 (-0.51; 0.58)
Prepubertal 10 10
Pubertal 12 12
Postpubertal 31 26
Diabetes duration (years) 53 6.0 (3.3; 10.3)
Insulin treatment 53
Multiple daily injections 26 (49%)
CSII 27 (51%)
HbA1c (%) 53 7.6 (6.9; 8.1)
HbA1c (mmol/mol) 53 60 (52; 65)
Microalbuminuria (mg/g creatinine/day) 43 6.0 (5.0; 10.0)
Cholesterol (mg/dl) 53 169 (151; 182)
HDL cholesterol (mg/dl) 53 51 (45; 60)
LDL cholesterol (mg/dl) 53 102 (80; 115)
Triglycerides (mg/dl) 53 58 (47; 75)
Data are reported as median (interquartile range) for continuous measures and n (%) for categorical measure. BMI = body mass index; Cacciari = Italian
reference data; CSII: continuous subcutaneous insulin infusion; HbA1c = glycated hemoglobin; HDL = high-density lipoprotein; IQR = interquartile range;
LDL = low-density lipoprotein; SDS = standard deviation score.
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of their size even when statistically significant. For
instance, the mean (SD) difference estimated by the frac-
tional GLM for S-Superior is -0.02 (95% CI -0.03 to
-0.01) for patients with type 1 diabetes vs. healthy subjects.
Although statistically significant, a reduction of 0.02 is
about 4% of the density (0.57) of the control group. Nev-
ertheless, it is interesting to note that in our analysis, the
temporal macular sectors resulted to be primarily affected
in both the SCP and DCP. This is in agreement with pre-
vious findings from other researches evidencing this sector
as a particularly susceptible portion of the macula [26].
Han et al. in 2017 described OCTA changes in patients
affected by various sickle cell genotypes describing greater
flow loss in the temporal subfields [26]. One of the main
explanations for this finding was that the temporal macu-
lar vessels are located within the watershed zones along
the horizontal raphe and consequently nearby terminal
vessels. This anatomical configuration may lead to increase
susceptibility of vascular damage for this sector. Also,
these results confirm previous researches showing retinal
thinning to be more prominent in the temporal sectors
in the same subset of patients.
Our results could suggest that in a cohort of well-
controlled children and young adults with short duration of
disease, alterations in retinal vessel density occur very early
and before the onset of other diabetes-related complications.
We could speculate that retina is one of the most sensitive
target tissues. The lack of correlation with median HbA1c
value since the disease onset could suggest that we should
try to look over hemoglobin A1C and search for new metrics
in the clinical practice to estimate the risk of diabetes-related
chronic complications. In this field, the role “time in range” is
emergent. In adults affected by type 2 diabetes, the lowest
percentage of time in range is associated with an increased
risk to have diabetic retinopathy and an increased severity
of eye damage [27, 28].
The prevalence of clinically detectable DR was very low in
our population, i.e., 3‰ (2/53 patients). The low frequency
and the mild form in our population of DR are not surprising
owing to the low median duration of disease of our patients
(6 years). It must also be pointed out that the median (IQR)
HbA1c at the time of OCTA was 7.6% (60 mmol/mol)
(6.9-8.1; 52-65 mmol/mol), which is compatible with a rea-
sonably good metabolic control in the last three months.
In our series, we performed both a qualitative and a
quantitative assessment of retinal vascular alterations occur-
ring in both populations. OCTA qualitative analysis showed
vascular abnormalities (microaneurysms, remodeling, and
capillary loss) in patients that had clinically detectable DR.
Similar qualitative microvascular abnormalities were also
detected on OCTA in a patient with long duration of disease
and suboptimal metabolic control since diagnosis but with a
normal fundus. Interestingly, all the three patients with
OCTA-detected retinal alterations had disease duration
above the median, i.e., 8, 11, and 20 years.
Even if this is one of the first studies to investigate the role
of OCTA in detecting early alterations of the macular capil-
lary network in pediatric patients with type 1 diabetes, it
has several limitations. First, this is a cross-sectional study,
and as such, it can evaluate the retinal vasculature status only
at a specific time point. A prospective evaluation of these
children will help us to describe the evolution of our findings.
Second, the population recruited is relatively small. The main
reason is the difficultly in recruiting children especially in
prepubertal age because OCTA requires patient’s collabora-
tion. However, considering the available studies published
so far on the use of OCTA in pediatric population affected
by type 1 diabetes without diabetic retinopathy, our cohort
was one of the largest.
Third, recent updates in OCTA software are looking for
the possibility to further split the DCP in two separate
vascular structures, and the recently described intermediate
Table 2: Vascular densities of the superficial and deep plexus in patients with type 1 diabetes and healthy controls.
Healthy controls (n = 96 eyes) Patients with type 1 diabetes (n = 106 eyes) p value
Mean 95% LCI 95% UCI Mean 95% LCI 95% UCI
S-Fovea 0.31 0.30 0.32 0.32 0.31 0.33 0.3025
S-Parafovea 0.58 0.57 0.58 0.57 0.56 0.57 0.0054
S-Temporal 0.57 0.56 0.57 0.55 0.54 0.55 <0.001
S-Superior 0.57 0.56 0.58 0.55 0.54 0.56 0.0028
S-Nasal 0.57 0.56 0.58 0.56 0.55 0.56 0.0068
S-Inferior 0.56 0.55 0.57 0.55 0.54 0.56 0.0229
D-Fovea 0.31 0.29 0.32 0.33 0.31 0.35 0.0404
D-Parafovea 0.65 0.65 0.65 0.64 0.64 0.65 0.0036
D-Temporal 0.65 0.64 0.65 0.63 0.63 0.64 <0.001
D-Superior 0.66 0.65 0.66 0.65 0.65 0.66 0.7267
D-Nasal 0.65 0.65 0.66 0.65 0.64 0.65 0.5897
D-Inferior 0.65 0.65 0.66 0.65 0.65 0.66 0.8462
Comparison of the vascular densities of the superficial and deep plexus in patients with type 1 diabetes and healthy controls. Values are means and 95%
confidence intervals estimated from a fractional generalized linear model (see Statistical Analysis for details).LCI = lower confidence interval; UCI = upper
confidence interval; S- = superficial plexus; D- = deep plexus.
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(b)
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(c)
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(d)
(d)
(e)
(e)
(f)
(f)
Figure 1: Optical coherence tomography angiography images. (a, b) Optical coherence tomography angiography (OCTA) in a healthy
control showing the typical spider web appearance of the superficial capillary plexus (SCP) (a) and the sea fan pattern of the deep capillary
plexus (DCP) (b). (c–f) SCP (c and e) and DCP (d and f) in two patients (c and d) patient #40; (e and f) patient #28) showing early
vascular changes at the level of both retinal plexus. In these cases, indeed mild capillary loss with reduced vascular density was better
visible at the level of the SCP whereas microaneurysms could be recognized at the level of the deep vascular structures. Arrow:
microaneurysm; arrowhead: areas of capillary drop-out.
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plexus may be primarily affected in the very early phases of
the disease.
5. Conclusions
This study investigates the role of OCTA in detecting early
vascular changes in pediatric patients with type 1 diabetes.
OCTA is confirmed to be a valuable tool for noninvasive
diagnosing and monitoring of these patients. In particular,
we found that microvascular changes in both SCP and DCP
could be reliably highlighted by means of OCTA before the
appearance of clinical signs of DR at fundoscopy. In our
series, the temporal sectors appeared to be more significantly
reduced compared to the other subfields thus possibly repre-
senting a primary site of pathology. Cohort studies are
needed to further evaluate the potential of OCTA for the
screening of DR in children with type 1 diabetes, for
improving the treatment of diabetes-related ocular disease
and to understand the relevance of intraocular early signs
in the progression of the systemic disease.
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